ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma

Trial Profile

ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 16 Jun 2017

At a glance

  • Drugs Cisplatin (Primary) ; Pemetrexed (Primary)
  • Indications Mesothelioma
  • Focus Expanded access; Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 16 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top